https://pubmed.ncbi.nlm.nih.gov/36978804/
Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the...
Erythropoietin (EPO) is neuroprotective in multiple models of neurodegenerative diseases, including glaucoma. EPO-R76E retains the neuroprotective effects of...
sustained release